Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma
Cited by 54
Related Papers
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
|Cell Death and Disease|2019|50
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors
|British Journal of Cancer|2025|7